Nabiximols Archives - Freedom Wares

PubMed is a free, comprehensive database of scientific and medical literature, primarily focusing on biomedical and life sciences research. It is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). PubMed is one of the most widely used resources for healthcare professionals, researchers, and students to access peer-reviewed articles, clinical studies, and other scientific publications.

Canna~Fangled Abstracts

Trends in prescription and cost of Sativex, a cannabinoid-based medicine, in treating patients with multiple sclerosis in England

Journal List J Pharm Policy Pract v.17(1); 2024 PMC11080669 As a library, NLM provides access…

Freedom WaresMay 8, 2024

Canna~Fangled Abstracts

Spasticity-Plus syndrome in multiple sclerosis patients in a tertiary hospital in Spain

Journal List Front Neurol PMC10926473 As a library, NLM provides access to scientific literature. Inclusion…

Freedom WaresFebruary 26, 2024

Canna~Fangled Abstracts

A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial

Journal List BMC Cancer v.24; 2024 PMC10790538 As a library, NLM provides access to scientific…

Freedom WaresJanuary 15, 2024

Canna~Fangled Abstracts

A post hoc evaluation of the shift in spasticity category in individuals with multiple sclerosis-related spasticity treated with nabiximols

Journal List Ther Adv Neurol Disord v.16; 2023 PMC10515604 As a library, NLM provides access…

Freedom WaresSeptember 21, 2023

Canna~Fangled Abstracts

Nabiximols oromucosal spray in patients with multiple sclerosis-related bladder dysfunction: A prospective study

Mult Scler Relat Disor. 2023 Apr 9;74:104711. doi: 10.1016/j.msard.2023.104711. Online ahead of print. Valentina Torri…

Freedom WaresApril 9, 2023

Canna~Fangled Abstracts

CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders – Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study

Psychiatry Res. 2023 Feb 28;323:115135. doi: 10.1016/j.psychres.2023.115135. Online ahead of print. Kirsten R Müller-Vahl 1, Anna Pisarenko 1, Natalia…

Freedom WaresFebruary 28, 2023

Canna~Fangled Abstracts

NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol

Biomed Pharmacother. 2022 Sep;153:113488. doi: 10.1016/j.biopha.2022.113488. Epub 2022 Aug 4. D Scuteri 1, F Guida 2, S Boccella 3, L Luongo 4, S Maione 5, P…

Freedom WaresSeptember 9, 2022

Canna~Fangled Abstracts

Cannabinoid Effect and Safety in Spasticity Following Stroke: A Double-Blind Randomized Placebo-Controlled Study

Front Neurol. 2022 Jun 23;13:892165. doi: 10.3389/fneur.2022.892165. eCollection 2022. Lucio Marinelli 1 2, Luca Puce 1, Laura Mori 1 3, Massimo Leandri 1, Gian Marco Rosa 4 5, Antonio…

Freedom WaresJune 23, 2022

Canna~Fangled Abstracts

Usability of an application device for nabiximols oromucosal spray in patients with upper limb impaired multiple sclerosis

Neurodegener Dis Manag. 2022 Jun 16. doi: 10.2217/nmt-2022-0014. Online ahead of print. Armando Creta 1, Luana Gilio 1, Diego…

Freedom WaresJune 16, 2022

Canna~Fangled Abstracts

Comparison of the Effectiveness and Tolerability of Nabiximols (THC:CBD) Oromucosal Spray versus Oral Dronabinol (THC) as Add-on Treatment for Severe Neuropathic Pain in Real-World Clinical Practice: Retrospective Analysis of the German Pain e-Registry

Journal List > J Pain Res > v.15; 2022 > PMC8819705 J Pain Res. 2022;…

Freedom WaresFebruary 2, 2022

Nabiximols

Trends in prescription and cost of Sativex, a cannabinoid-based medicine, in treating patients with multiple sclerosis in England

Spasticity-Plus syndrome in multiple sclerosis patients in a tertiary hospital in Spain

A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial

A post hoc evaluation of the shift in spasticity category in individuals with multiple sclerosis-related spasticity treated with nabiximols

Nabiximols oromucosal spray in patients with multiple sclerosis-related bladder dysfunction: A prospective study

CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders – Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study

NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol

Cannabinoid Effect and Safety in Spasticity Following Stroke: A Double-Blind Randomized Placebo-Controlled Study

Usability of an application device for nabiximols oromucosal spray in patients with upper limb impaired multiple sclerosis

Comparison of the Effectiveness and Tolerability of Nabiximols (THC:CBD) Oromucosal Spray versus Oral Dronabinol (THC) as Add-on Treatment for Severe Neuropathic Pain in Real-World Clinical Practice: Retrospective Analysis of the German Pain e-Registry

Recent Posts

Archives

Categories